Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2020 4
2021 6
2022 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yingtan chan (1 results)?
Nutraceuticals and COVID-19: A mechanistic approach toward attenuating the disease complications.
Paudel KR, Patel V, Vishwas S, Gupta S, Sharma S, Chan Y, Jha NK, Shrestha J, Imran M, Panth N, Shukla SD, Jha SK, Devkota HP, Warkiani ME, Singh SK, Ali MK, Gupta G, Chellappan DK, Hansbro PM, Dua K. Paudel KR, et al. Among authors: chan y. J Food Biochem. 2022 Dec;46(12):e14445. doi: 10.1111/jfbc.14445. Epub 2022 Oct 14. J Food Biochem. 2022. PMID: 36239436 Free PMC article. Review.
Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems.
Prasher P, Sharma M, Singh SK, Gulati M, Jha NK, Gupta PK, Gupta G, Chellappan DK, Zacconi F, de Jesus Andreoli Pinto T, Chan Y, Liu G, Paudel KR, Hansbro PM, George Oliver BG, Dua K. Prasher P, et al. Among authors: chan y. Chem Biol Interact. 2022 Sep 25;365:110048. doi: 10.1016/j.cbi.2022.110048. Epub 2022 Aug 4. Chem Biol Interact. 2022. PMID: 35932910 Review.
Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models.
Tan CL, Chan Y, Candasamy M, Chellian J, Madheswaran T, Sakthivel LP, Patel VK, Chakraborty A, MacLoughlin R, Kumar D, Verma N, Malyla V, Gupta PK, Jha NK, Thangavelu L, Devkota HP, Bhatt S, Prasher P, Gupta G, Gulati M, Singh SK, Paudel KR, Hansbro PM, Oliver BG, Dua K, Chellappan DK. Tan CL, et al. Among authors: chan y. Eur J Pharmacol. 2022 Mar 15;919:174821. doi: 10.1016/j.ejphar.2022.174821. Epub 2022 Feb 11. Eur J Pharmacol. 2022. PMID: 35151643 Review.
Renal Nano-drug delivery for acute kidney Injury: Current status and future perspectives.
Geo HN, Murugan DD, Chik Z, Norazit A, Foo YY, Leo BF, Teo YY, Kadir SZSBSA, Chan Y, Chai HJ, Medel M, Abdullah NA, Johns EJ, Vicent MJ, Chung LY, Kiew LV. Geo HN, et al. Among authors: chan y. J Control Release. 2022 Mar;343:237-254. doi: 10.1016/j.jconrel.2022.01.033. Epub 2022 Jan 24. J Control Release. 2022. PMID: 35085695 Review.
Recent Trends in Rationally Designed Molecules as Kinase Inhibitors.
Prasher P, Sharma M, Chan Y, Singh SK, Anand K, Dureja H, Jha NK, Gupta G, Zacconi F, Chellappan DK, Dua K. Prasher P, et al. Among authors: chan y. Curr Med Chem. 2023;30(13):1529-1567. doi: 10.2174/0929867328666211111161811. Curr Med Chem. 2023. PMID: 34766883 Review.
Versatility of liquid crystalline nanoparticles in inflammatory lung diseases.
Chan Y, Mehta M, Paudel KR, Madheswaran T, Panneerselvam J, Gupta G, Su QP, Hansbro PM, MacLoughlin R, Dua K, Chellappan DK. Chan Y, et al. Nanomedicine (Lond). 2021 Aug;16(18):1545-1548. doi: 10.2217/nnm-2021-0114. Epub 2021 Jun 29. Nanomedicine (Lond). 2021. PMID: 34184917 No abstract available.
18 results